A nomogram based on age, grade, T stage (tumor size), N stage (nodal metastasis status), and SAT2 expression levels was developed to predict the survival rate at both one and two years in PC patients (Figure 3C), which accurately predicted the clinical outcomes at these time points, according to the calibration curves (Figure 3D). This evidence concerns the gene SAT2 and pachyonychia congenita.